No |
Initial |
Age at dx |
Phase |
Sokal’s risk |
Mutation at diagnosis |
Response |
P-loop |
Outside P-loop |
1 |
PP |
28 |
Chronic |
Low |
NM |
NM |
CHR within 3 months |
2 |
N |
24 |
Chronic |
Low |
NM |
NM |
CHR within 3 months |
3 |
AL |
38 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
4 |
JR |
61 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
5 |
F |
24 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
6 |
SR |
45 |
Chronic |
Low |
NM |
NM |
CHR within 3 months |
7 |
M |
36 |
Chronic |
High |
NM |
n.1152 C→T(silent mutation) |
Drop out |
8 |
KKK (†) |
47 |
Chronic |
Intermediate |
NM |
V506S |
No response |
9 |
UBW (†) |
54 |
Chronic |
High |
NM |
N231Q |
No response |
10 |
A (†) |
45 |
Chronic |
High |
NM |
c.661_662insG and c.1555_1557insG |
No response |
11 |
I |
59 |
Accelerated |
Low |
NM |
NM |
CHR in 4 to 6 months |
12 |
AP |
20 |
Accelerated |
High |
NM |
NM |
CHR in 10 to 12 months |
13 |
AH (†) |
50 |
Accelerated |
High |
NM |
E509G |
No response |
14 |
H (†) |
41 |
Blast crisis |
High |
NM |
NM |
No response |
15 |
M (†) |
51 |
Chronic |
High |
NM |
NM |
No response |
16 |
TS |
56 |
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
17 |
S |
32 |
Chronic |
High |
NM |
NM |
CHR in 7 to 9 months |
18 |
ME |
32 |
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
19 |
MFA (†) |
39 |
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
20 |
ES |
34 |
Accelerated |
High |
NM |
NM |
CHR within 3 months |
21 |
PR |
39 |
Accelerated |
High |
NM |
NM |
CHR in 4 to 6 months |
22 |
S (†) |
21 |
Blast crisis |
High |
NM |
NM |
No response |
23 |
TF |
26 |
Blast crisis |
High |
NM |
NM |
CHR within 3 months |
24 |
MA |
34 |
Chronic |
High |
NM |
NM |
CHR within 3 months |
25 |
YNK |
40 |
Chronic |
Intermediate |
NM |
NM |
Not determined |
26 |
WG |
|
Chronic |
Low |
NM |
NM |
CHR within 3 months |
27 |
HY |
|
Chronic |
High |
NM |
M351T |
Died of blastic crisis |
28 |
Was |
|
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
29 |
WF |
|
Chronic |
Intermediate |
NM |
NM |
Died of blastic crisis |
30 |
UK |
|
Chronic |
High |
NM |
NM |
Died of blastic crisis |
31 |
TF |
|
Blast crisis |
High |
NM |
NM |
Not MMR |
32 |
TA |
|
Blast crisis |
High |
NM |
NM |
CHR within 3 months |
33 |
Syaf |
|
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
34 |
Sur |
|
Chronic |
Low |
NM |
NM |
CHR within 3 months |
35 |
Sol |
|
Chronic |
High |
NM |
NM |
Died of blastic crisis |
36 |
SA |
|
Chronic |
High |
NM |
NM |
Died of blastic crisis |
37 |
RP |
|
Chronic |
Intermediate |
NM |
NM |
CHR within 3 months |
38 |
RSu |
|
Accelerated |
High |
NM |
NM |
CHR within 3 months |
39 |
R So |
|
Chronic |
Low |
NM |
NM |
CHR within 3 months |
40 |
RY |
|
Chronic |
High |
NM |
NM |
CHR within 3 months |
41 |
PR |
|
Accelerated |
High |
NM |
NM |
CHR within 3 months |
42 |
NM |
|
Accelated |
High |
NM |
NM |
No MMR, but still alive |
43 |
NS |
|
Chronic |
High |
NM |
NM |
CHR within 3 months |
44 |
TS |
|
Chronic |
Intermediate |
Y253H |
NM |
Died during 15 mo’s IM treatment |
*NM: no mutation |
|